May 24, 2018 5:14 PM ET


Company Overview of Labopharm Inc.

Key Executives for Labopharm Inc.

NameBoard RelationshipsTitleAge
Mark A. D'Souza 6 RelationshipsChief Executive Officer, President and Director56
Sylvain Guénette CANo RelationshipsChief Financial Officer--
Anthony C. Playle No RelationshipsManaging Director of Labopharm Europe Limited--
Damon C. Smith BSc, Ph.D.No RelationshipsSenior Vice President of Research & Development--

Labopharm Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Santo J. Costa 60 RelationshipsCytokinetics, Incorporated71
Mark A. D'Souza 6 RelationshipsLabopharm Inc.56
Jacques L. Roy 6 RelationshipsLabopharm Inc.--
Julia R. Brown 39 RelationshipsAlbireo Pharma, Inc.70
Rachel R. Selisker CPA 6 RelationshipsPeerMed Media Inc.61
View All Board Members

Labopharm Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CPARachel R. Selisker6 Relationships3 Executives
Compensation Committee Julia R. Brown39 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$328.8K
Total Value of Options
Compensation as of Fiscal Year
Labopharm Inc. CEO Compensation
Industry Average


Novartis Announces Executive Committee Changes
May 16, 2018 12:00 AM ET
Sosei Group Corporation Announces Board Changes
May 15, 2018 11:30 PM ET
India Globalization Capital, Inc. Appoints Claudia Grimaldi as Vice-President and Principal Financial Officer
May 15, 2018 8:16 PM ET
Astellas Pharma Inc. Appoints Bernhardt Zeiher, as New Chief Medical Officer
May 15, 2018 8:00 PM ET
Moberg Pharma AB (Publ) Announces Board Changes
May 15, 2018 6:16 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Labopharm Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at